What is it about?
The study characterizes a device that can take a sample of the Ebola virus genomic material and report the sequence in 24 hours. Knowing the sequence of a patient's infection will permit rapid decision-making about the best treatment, where the infection likely originated and the potential impact on the community.
Photo by CDC on Unsplash
Why is it important?
The importance of this study is the thorough demonstration of the proficiency of the Ebola microarray and the impact that clinical availability of such a device would make.
Read the Original
This page is a summary of: Tracking ebolavirus genomic drift with a resequencing microarray, PLoS ONE, February 2022, PLOS, DOI: 10.1371/journal.pone.0263732.
You can read the full text:
The following have contributed to this page